Concepts (121)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Brain Diseases | 3 | 2021 | 1463 | 0.81 | Why? |
| Shock, Septic | 3 | 2018 | 1313 | 0.79 | Why? |
| Eicosapentaenoic Acid | 1 | 2017 | 106 | 0.66 | Why? |
| Docosahexaenoic Acids | 1 | 2017 | 145 | 0.62 | Why? |
| Arteries | 1 | 2017 | 283 | 0.59 | Why? |
| Neutrophil Activation | 1 | 2018 | 510 | 0.56 | Why? |
| Delirium | 2 | 2021 | 1061 | 0.51 | Why? |
| Editorial Policies | 1 | 2018 | 408 | 0.50 | Why? |
| Pulmonary Embolism | 3 | 2020 | 4775 | 0.47 | Why? |
| Brain | 5 | 2021 | 5133 | 0.44 | Why? |
| Autopsy | 1 | 2020 | 3495 | 0.38 | Why? |
| Vascular Diseases | 1 | 2017 | 846 | 0.37 | Why? |
| Fibrin Fibrinogen Degradation Products | 3 | 2021 | 5993 | 0.35 | Why? |
| Severe Acute Respiratory Syndrome | 2 | 2020 | 12361 | 0.31 | Why? |
| Confusion | 2 | 2020 | 256 | 0.23 | Why? |
| Anticoagulants | 2 | 2020 | 9563 | 0.22 | Why? |
| Nervous System Diseases | 1 | 2020 | 4092 | 0.22 | Why? |
| Thrombosis | 2 | 2021 | 7504 | 0.22 | Why? |
| Extracorporeal Membrane Oxygenation | 4 | 2020 | 5002 | 0.22 | Why? |
| Myelopoiesis | 1 | 2021 | 116 | 0.21 | Why? |
| Critical Care | 5 | 2021 | 14081 | 0.20 | Why? |
| Iohexol | 1 | 2019 | 42 | 0.20 | Why? |
| Stroke | 2 | 2020 | 8839 | 0.20 | Why? |
| Metabolic Clearance Rate | 1 | 2019 | 110 | 0.20 | Why? |
| Immunity, Innate | 1 | 2018 | 6570 | 0.20 | Why? |
| Epoprostenol | 1 | 2017 | 41 | 0.18 | Why? |
| Pneumonia, Viral | 10 | 2020 | 243684 | 0.18 | Why? |
| Coronavirus Infections | 10 | 2020 | 253789 | 0.17 | Why? |
| Meningoencephalitis | 1 | 2020 | 208 | 0.17 | Why? |
| Neovascularization, Pathologic | 1 | 2021 | 305 | 0.17 | Why? |
| Kidney Function Tests | 1 | 2019 | 520 | 0.17 | Why? |
| Norepinephrine | 1 | 2017 | 152 | 0.17 | Why? |
| Magnetic Resonance Imaging | 4 | 2021 | 6551 | 0.16 | Why? |
| Environmental Pollutants | 1 | 2021 | 320 | 0.15 | Why? |
| Conflict of Interest | 1 | 2018 | 175 | 0.15 | Why? |
| Rats, Wistar | 1 | 2017 | 621 | 0.15 | Why? |
| Propensity Score | 2 | 2021 | 2690 | 0.14 | Why? |
| Research Support as Topic | 1 | 2018 | 327 | 0.14 | Why? |
| Disclosure | 1 | 2018 | 423 | 0.13 | Why? |
| Creatinine | 1 | 2019 | 1443 | 0.12 | Why? |
| Positive-Pressure Respiration | 1 | 2021 | 1160 | 0.12 | Why? |
| Betacoronavirus | 9 | 2020 | 204454 | 0.12 | Why? |
| France | 4 | 2021 | 12074 | 0.11 | Why? |
| Body Mass Index | 2 | 2021 | 4306 | 0.11 | Why? |
| Nitric Oxide | 1 | 2017 | 769 | 0.11 | Why? |
| Rats | 1 | 2017 | 2764 | 0.10 | Why? |
| Renal Replacement Therapy | 1 | 2018 | 1530 | 0.10 | Why? |
| Phenotype | 1 | 2020 | 4037 | 0.09 | Why? |
| Humans | 23 | 2021 | 930598 | 0.08 | Why? |
| Intensive Care Units | 4 | 2021 | 29594 | 0.08 | Why? |
| Pandemics | 10 | 2020 | 389249 | 0.08 | Why? |
| Oxidative Stress | 1 | 2017 | 2050 | 0.08 | Why? |
| Critical Illness | 5 | 2021 | 17281 | 0.08 | Why? |
| Aged | 11 | 2021 | 215776 | 0.08 | Why? |
| Middle Aged | 13 | 2021 | 270681 | 0.08 | Why? |
| Adaptive Immunity | 1 | 2018 | 2585 | 0.08 | Why? |
| Periodicals as Topic | 1 | 2018 | 1492 | 0.07 | Why? |
| Heparin | 1 | 2018 | 2600 | 0.07 | Why? |
| Thrombocytopenia | 1 | 2018 | 2093 | 0.07 | Why? |
| Brain Ischemia | 1 | 2020 | 2813 | 0.07 | Why? |
| Renal Insufficiency, Chronic | 1 | 2019 | 2654 | 0.07 | Why? |
| Male | 13 | 2021 | 367725 | 0.06 | Why? |
| Fibroblast Growth Factor 2 | 1 | 2021 | 77 | 0.06 | Why? |
| Time-to-Treatment | 1 | 2018 | 5883 | 0.06 | Why? |
| Pneumonia | 1 | 2021 | 5652 | 0.06 | Why? |
| Neutrophils | 1 | 2018 | 5476 | 0.06 | Why? |
| Pyramidal Tracts | 1 | 2020 | 66 | 0.05 | Why? |
| Sepsis | 1 | 2018 | 3517 | 0.05 | Why? |
| Female | 12 | 2021 | 380317 | 0.05 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.05 | Why? |
| Cohort Studies | 2 | 2020 | 36005 | 0.05 | Why? |
| Meningitis | 1 | 2020 | 163 | 0.05 | Why? |
| Psychomotor Agitation | 1 | 2020 | 208 | 0.05 | Why? |
| Pulmonary Gas Exchange | 1 | 2021 | 414 | 0.05 | Why? |
| Acute Kidney Injury | 1 | 2018 | 5762 | 0.04 | Why? |
| Pipecolic Acids | 1 | 2018 | 84 | 0.04 | Why? |
| Incidence | 1 | 2020 | 25622 | 0.04 | Why? |
| Prospective Studies | 2 | 2020 | 43301 | 0.04 | Why? |
| Blood Gas Analysis | 1 | 2021 | 893 | 0.04 | Why? |
| Consciousness Disorders | 1 | 2020 | 335 | 0.04 | Why? |
| Vascular Endothelial Growth Factor A | 1 | 2021 | 604 | 0.04 | Why? |
| Respiratory Mechanics | 1 | 2021 | 585 | 0.04 | Why? |
| Blood-Brain Barrier | 1 | 2021 | 531 | 0.04 | Why? |
| Interleukin-1beta | 1 | 2021 | 992 | 0.04 | Why? |
| Arginine | 1 | 2018 | 377 | 0.04 | Why? |
| von Willebrand Factor | 1 | 2021 | 668 | 0.04 | Why? |
| Industry | 1 | 2018 | 347 | 0.04 | Why? |
| Adult | 7 | 2020 | 244371 | 0.04 | Why? |
| Retrospective Studies | 6 | 2021 | 105322 | 0.03 | Why? |
| Respiratory Function Tests | 1 | 2021 | 1755 | 0.03 | Why? |
| Cerebral Hemorrhage | 1 | 2020 | 820 | 0.03 | Why? |
| Encephalitis | 1 | 2020 | 797 | 0.03 | Why? |
| Israel | 1 | 2021 | 2751 | 0.03 | Why? |
| Treatment Failure | 1 | 2018 | 2106 | 0.03 | Why? |
| Platelet Count | 1 | 2018 | 1381 | 0.03 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.03 | Why? |
| Shock, Cardiogenic | 1 | 2018 | 700 | 0.03 | Why? |
| Membrane Proteins | 1 | 2021 | 1733 | 0.03 | Why? |
| Endothelial Cells | 1 | 2021 | 2048 | 0.03 | Why? |
| Computed Tomography Angiography | 1 | 2020 | 2153 | 0.02 | Why? |
| Headache | 1 | 2020 | 2257 | 0.02 | Why? |
| Sulfonamides | 1 | 2018 | 1294 | 0.02 | Why? |
| Research Personnel | 1 | 2018 | 1037 | 0.02 | Why? |
| Animals | 1 | 2017 | 78931 | 0.02 | Why? |
| Platelet Aggregation Inhibitors | 1 | 2018 | 1671 | 0.02 | Why? |
| Survival Analysis | 1 | 2018 | 7592 | 0.02 | Why? |
| Europe | 1 | 2021 | 12702 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2018 | 7220 | 0.02 | Why? |
| Interleukin-6 | 1 | 2021 | 7522 | 0.02 | Why? |
| Treatment Outcome | 2 | 2020 | 51732 | 0.02 | Why? |
| Kidney Failure, Chronic | 1 | 2018 | 3222 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2020 | 88759 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2018 | 10649 | 0.01 | Why? |
| Young Adult | 2 | 2020 | 93724 | 0.01 | Why? |
| Inflammation | 1 | 2021 | 13255 | 0.01 | Why? |
| Biomarkers | 1 | 2021 | 23361 | 0.01 | Why? |
| Prevalence | 1 | 2018 | 25773 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2021 | 22116 | 0.01 | Why? |
| United States | 1 | 2021 | 46150 | 0.01 | Why? |
| Child | 1 | 2020 | 70012 | 0.01 | Why? |
| Adolescent | 1 | 2020 | 86841 | 0.01 | Why? |
Helms's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(121)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(232)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_